145 related articles for article (PubMed ID: 30777670)
21. Celecoxib-induced bullous fixed drug eruption: An unusual presentation.
Ammar H; Ben Fredj N; Ben Fadhel N; Chadli Z; Ben Romdhane H; Boughattas NA; Chaabane A; Aouam K
Br J Clin Pharmacol; 2019 Nov; 85(11):2638-2639. PubMed ID: 31376180
[No Abstract] [Full Text] [Related]
22. Delayed-type hypersensitivity to bupivacaine.
Nettis E; Colanardi MC; Calogiuri GF; Foti C; Priore MG; Ferrannini A; Vacca A
Allergy; 2007 Nov; 62(11):1345-6. PubMed ID: 17822450
[No Abstract] [Full Text] [Related]
23. A nonscarring sublamina densa bullous drug eruption.
Roholt NS; Lapiere JC; Traczyk T; Chan LS; Woodley DT
J Am Acad Dermatol; 1995 Feb; 32(2 Pt 2):367-71. PubMed ID: 7829742
[TBL] [Abstract][Full Text] [Related]
24. Repeated patch testing in delayed hypersensitivity to beta-lactam antibiotics.
Romano A; Di Fonso M; Pietrantonio F; Pocobelli D; Giannarini L; Del Bono A; Fabrizi G; Venuti A
Contact Dermatitis; 1993 Mar; 28(3):190. PubMed ID: 8462302
[No Abstract] [Full Text] [Related]
25. Fixed drug eruption caused by mesna.
Weiss KM; Jariwala S; Wachs J; Jerschow E
Ann Allergy Asthma Immunol; 2011 Oct; 107(4):377-8. PubMed ID: 21962104
[No Abstract] [Full Text] [Related]
26. Mesalazine-induced bullous fixed drug eruption.
Salman A; Seckin Gencosmanoglu D; Alahdab YO; Giménez-Arnau AM
Contact Dermatitis; 2018 Jul; 79(1):34-35. PubMed ID: 29446099
[No Abstract] [Full Text] [Related]
27. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions.
Hassoun-Kheir N; Bergman R; Weltfriend S
Int J Dermatol; 2016 Nov; 55(11):1219-1224. PubMed ID: 27368159
[TBL] [Abstract][Full Text] [Related]
28. Positivity of patch tests in cutaneous reaction to diclofenac. Two case reports.
Romano A; Pietrantonio F; Di Fonso M; Garcovich A; Chiarelli C; Venuti A; Barone C
Allergy; 1994 Jan; 49(1):57-9. PubMed ID: 8198241
[TBL] [Abstract][Full Text] [Related]
29. Probable Etoricoxib-Induced Severe Thrombocytopenia: A Case Report.
Recinella G; De Marchi A; Pirazzoli E; Bianchi G
Med Princ Pract; 2019; 28(4):387-389. PubMed ID: 30650407
[TBL] [Abstract][Full Text] [Related]
30. Etoricoxib-induced toxic epidermal necrolysis: A fatal case report.
Roy SS; Mukherjee S; Era N; Mukherjee M
Indian J Pharmacol; 2018; 50(3):139-142. PubMed ID: 30166751
[TBL] [Abstract][Full Text] [Related]
31. Delayed-type hypersensitivity reaction to heparin.
Korstanje MJ; Bessems PJ; Hardy E; van de Staak WJ
Contact Dermatitis; 1989 May; 20(5):383-4. PubMed ID: 2527721
[No Abstract] [Full Text] [Related]
32. Delayed cell-mediated hypersensitivity to tetrazepam.
Ortega NR; Barranco P; López Serrano C; Romualdo L; Mora C
Contact Dermatitis; 1996 Feb; 34(2):139. PubMed ID: 8681544
[No Abstract] [Full Text] [Related]
33. Bullous fixed drug eruption related to multivitamins.
Jha N
Dermatol Online J; 2020 Sep; 26(9):. PubMed ID: 33054952
[TBL] [Abstract][Full Text] [Related]
34. Delayed hypersensitivity to scopolamine delivered by a transdermal device.
Trozak DJ
J Am Acad Dermatol; 1985 Aug; 13(2 Pt 1):247-51. PubMed ID: 2931457
[TBL] [Abstract][Full Text] [Related]
35. Rash from oral codeine.
van Ketel WG
Contact Dermatitis; 1986 Sep; 15(3):195. PubMed ID: 2946544
[No Abstract] [Full Text] [Related]
36. Azithromycin induced bullous fixed drug eruption.
Das A; Sancheti K; Podder I; Das NK
Indian J Pharmacol; 2016; 48(1):83-5. PubMed ID: 26997729
[TBL] [Abstract][Full Text] [Related]
37. Delayed-type sensitivity reaction to mitomycin.
Giorgini S; Martinelli C; Sertoli A
Contact Dermatitis; 1991 May; 24(5):378-9. PubMed ID: 1832622
[No Abstract] [Full Text] [Related]
38. Evaluation of skin test reactions in patients with non-immediate type drug eruptions.
Osawa J; Naito S; Aihara M; Kitamura K; Ikezawa Z; Nakajima H
J Dermatol; 1990 Apr; 17(4):235-9. PubMed ID: 2142173
[TBL] [Abstract][Full Text] [Related]
39. Delayed and immediate hypersensitivity reactions associated with the use of amalgam.
McGivern B; Pemberton M; Theaker ED; Buchanan JA; Thornhill MH
Br Dent J; 2000 Jan; 188(2):73-6. PubMed ID: 10689768
[TBL] [Abstract][Full Text] [Related]
40. Delayed genital blisters following iodixanol administration.
Zhang W; Yuan W; Yuan HL; Yang XL; Xie H
Clin Toxicol (Phila); 2017 Sep; 55(8):939-940. PubMed ID: 28463024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
